TKNO insider trading
NasdaqGM HealthcareAlpha Teknova, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Alpha Teknova, Inc.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Company website: www.teknova.com
TKNO insider activity at a glance
FilingIQ has scored 69 insider transactions for TKNO since Jun 28, 2021. The most recent filing in our index is dated Mar 6, 2026.
Across the full history, 35 open-market purchases
and 4 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TKNO insider trades is 54.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TKNO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading TKNO
Frequently asked
- How many insider trades does FilingIQ track for TKNO?
- FilingIQ tracks 69 Form 4 insider transactions for TKNO (Alpha Teknova, Inc.), covering filings from Jun 28, 2021 onwards. 5 of those were filed in the last 90 days.
- Are TKNO insiders net buyers or net sellers?
- Across the full Form 4 history for TKNO, 35 transactions (51%) were open-market purchases and 4 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TKNO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is TKNO in?
- Alpha Teknova, Inc. (TKNO) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $110.27M.
Methodology & sources
Every TKNO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.